Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
37.45
-0.17 (-0.45%)
At close: Feb 27, 2026, 4:00 PM EST
37.49
+0.04 (0.10%)
After-hours: Feb 27, 2026, 7:59 PM EST
Novo Nordisk Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.80B | 12.82B | 3.15B |
| Jun 30, 2025 | 33.61B | 12.46B | 3.13B |
| Mar 31, 2025 | 33.39B | 11.44B | 2.98B |
| Dec 31, 2024 | 32.59B | 10.27B | 2.94B |
| Sep 30, 2024 | 31.24B | 8.67B | 2.76B |
| Jun 30, 2024 | 30.40B | 7.64B | 2.65B |
| Mar 31, 2024 | 28.77B | 7.07B | 2.68B |
| Dec 31, 2023 | 27.36B | 6.57B | 2.71B |
| Sep 30, 2023 | 25.42B | 5.66B | 2.75B |
| Jun 30, 2023 | 24.40B | 4.41B | 2.94B |
| Mar 31, 2023 | 23.22B | 3.36B | 3.12B |
| Dec 31, 2022 | 22.01B | 2.66B | 3.24B |
| Sep 30, 2022 | 20.97B | 2.18B | 3.22B |
| Jun 30, 2022 | 19.80B | 1.88B | 3.12B |
| Mar 31, 2022 | 18.80B | 1.62B | 3.09B |
| Dec 31, 2021 | 17.85B | 1.32B | 3.03B |
| Sep 30, 2021 | 16.66B | 1.13B | 2.99B |
| Jun 30, 2021 | 15.88B | 980.35M | 3.04B |
| Mar 31, 2021 | 15.56B | 893.61M | 3.01B |
| Dec 31, 2020 | 15.32B | 895.66M | 3.03B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.